LakeShore Biopharma Co., Ltd — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/dfe8d19d-c043-4868-b4a0-6b3955ce697e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $85.7M | 2024-04-01 – 2025-03-31 | evidence 0001213900-25-069880 |
| FY 2023 | $80.8M | 2023-04-01 – 2024-03-31 | evidence 0001213900-24-069344 |
| FY 2022 | $100.0M | 2022-04-01 – 2023-03-31 | evidence 0001213900-23-060012 |
| FY 2021 | — | 2021-04-01 – 2022-03-31 | evidence 0001213900-23-060012 |
| FY 2020 | — | 2020-04-01 – 2021-03-31 | evidence 0001213900-23-060012 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
LakeShore Biopharma Co., Ltd — all facts · Net Income · Operating Income